← Open Payments lookup

VINAY KAMAT: Open Payments

NPI 1760522916 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$39,924 in 45 payments from 10 companies in 2025. Trend: 2023 $34,232 · 2024 $15,163 · 2025 $39,924

Speaker / faculty: $36,055Travel & lodging: $2,777Food & beverage: $1,092
CompanyPaymentsAmount
Novo Nordisk Inc33$39,642
ABBVIE INC.4$77
GENZYME CORPORATION1$74
Azurity Pharmaceuticals, Inc.1$24
E.R. Squibb & Sons, L.L.C.1$20
HEARTFLOW, INC.1$20
GlaxoSmithKline, LLC.1$18
Boehringer Ingelheim Pharmaceuticals, Inc.1$18
Novartis Pharmaceuticals Corporation1$17
Sumitomo Pharma America, Inc.1$14

Products named: Wegovy, KEVZARA, UBRELVY, VRAYLAR, ELIQUIS, FFRct, SHINGRIX, JARDIANCE.

Industry payments across MO — which companies pay providers there.